Ideaya Biosciences: Long-Tailed Pipeline With Positive Mid-Stage Data And Huge Cash

I covered Ideaya Biosciences, Inc. (NASDAQ: IDYA ) in December last year, and the stock had a great run for a while, before returning more or less to its December position. That "idiopathic" bullish run started in early January and continuedAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research ma ...